Aids

On-site access to PrEP during a clinical trial reduced HIV incidence by around 50%, according to a study of South African women published in The Lancet HIV.

The United Nations convened a high-level meeting this week to review progress made in the past 5 years since global leaders adopted strategies to eliminate HIV/AIDS as a public health threat by 2030.

June 5 marks 40 years since MMWR published a report of five cases of Pneumocystis pneumonia among young men in Los Angeles — the first report of what would come to be called AIDS.

The annual incidence of HIV in the United States declined 73% from a peak of 130,400 infections in 1984 and 1985 to 34,800 infections in 2019, according to estimates published today in MMWR.

Researchers in San Francisco found that people with HIV had fewer SARS-CoV-2 infections but experienced more cases of severe COVID-19 than people without HIV.

Researchers found that a clinical rotation in an HIV primary care clinic, paired with a specially curated curriculum, increased medical students’ — and even internal medicine residents’ — interest in a career in infectious diseases.

ViiV Healthcare said Tuesday that it has initiated a rolling submission of a new drug application for long-acting injectable cabotegravir for HIV PrEP.

A point-of-care model, consisting of 13 variables and available via a web-based calculator, was able to identify predictors for missing HIV health care visits, according to a recent study.

With increased funding for measures to end HIV as an epidemic in the United States, the Biden budget plan takes an important step toward addressing the challenge of ongoing and future pandemics.

Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.